Author:
Østergaard Jesper,Meng-Lund Emil,Larsen Susan Weng,Larsen Claus,Petersson Karsten,Lenke James,Jensen Henrik
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Organic Chemistry,Pharmaceutical Science,Pharmacology,Molecular Medicine,Biotechnology
Reference23 articles.
1. Clark BC, Dickinson PA, Pyrah IT. In vitro/in vivo release from injectable dispersed systems. In: Burgess DJ, editor. Injectable dispersed systems. Formulation, processing, and performance. Boca Raton: Taylor and Francis; 2005. p. 125–57.
2. Dutta S, Qiu Y, Samara E, Cao G, Granneman GR. Once-a-day extended-release dosage form of divalproex sodium III: development and validation of a level A in vitro-in vivo correlation (IVIVC). J Pharm Sci. 2005;94:1949–56.
3. Soto E, Haertter S, Koenen-Bergmann M, Staab A, Troconiz IF. Population in vitro–in vivo correlation model for pramipexole slow-release oral formulations. Pharm Res. 2010;27:340–9.
4. Takka S, Sakr A, Goldberg A. Development and validation of an in vitro–in vivo correlation for buspirone hydrochloride extended release tablets. J Control Release. 2003;88:147–57.
5. Larsen C, Larsen SW, Jensen H, Yaghmur A, Østergaard J. Role of in vitro release models in formulation development and quality control of parenteral depots. Expert Opin Drug Deliv. 2009;6:1283–95.
Cited by
73 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献